Tourette Syndrome Treatment Market
1 Introduction to Research & Analysis Reports
1.1 Tourette Syndrome Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tourette Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tourette Syndrome Treatment Overall Market Size
2.1 Global Tourette Syndrome Treatment Market Size: 2021 VS 2028
2.2 Global Tourette Syndrome Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tourette Syndrome Treatment Players in Global Market
3.2 Top Global Tourette Syndrome Treatment Companies Ranked by Revenue
3.3 Global Tourette Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Tourette Syndrome Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tourette Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tourette Syndrome Treatment Players in Global Market
3.6.1 List of Global Tier 1 Tourette Syndrome Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Tourette Syndrome Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Tourette Syndrome Treatment Market Size Markets, 2021 & 2028
4.1.2 Antipsychotics
4.1.3 Non Antipsychotics
4.2 By Type - Global Tourette Syndrome Treatment Revenue & Forecasts
4.2.1 By Type - Global Tourette Syndrome Treatment Revenue, 2017-2022
4.2.2 By Type - Global Tourette Syndrome Treatment Revenue, 2023-2028
4.2.3 By Type - Global Tourette Syndrome Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tourette Syndrome Treatment Market Size, 2021 & 2028
5.1.2 Children
5.1.3 Adult
5.2 By Application - Global Tourette Syndrome Treatment Revenue & Forecasts
5.2.1 By Application - Global Tourette Syndrome Treatment Revenue, 2017-2022
5.2.2 By Application - Global Tourette Syndrome Treatment Revenue, 2023-2028
5.2.3 By Application - Global Tourette Syndrome Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Tourette Syndrome Treatment Market Size, 2021 & 2028
6.2 By Region - Global Tourette Syndrome Treatment Revenue & Forecasts
6.2.1 By Region - Global Tourette Syndrome Treatment Revenue, 2017-2022
6.2.2 By Region - Global Tourette Syndrome Treatment Revenue, 2023-2028
6.2.3 By Region - Global Tourette Syndrome Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Tourette Syndrome Treatment Revenue, 2017-2028
6.3.2 US Tourette Syndrome Treatment Market Size, 2017-2028
6.3.3 Canada Tourette Syndrome Treatment Market Size, 2017-2028
6.3.4 Mexico Tourette Syndrome Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Tourette Syndrome Treatment Revenue, 2017-2028
6.4.2 Germany Tourette Syndrome Treatment Market Size, 2017-2028
6.4.3 France Tourette Syndrome Treatment Market Size, 2017-2028
6.4.4 U.K. Tourette Syndrome Treatment Market Size, 2017-2028
6.4.5 Italy Tourette Syndrome Treatment Market Size, 2017-2028
6.4.6 Russia Tourette Syndrome Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Tourette Syndrome Treatment Market Size, 2017-2028
6.4.8 Benelux Tourette Syndrome Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Tourette Syndrome Treatment Revenue, 2017-2028
6.5.2 China Tourette Syndrome Treatment Market Size, 2017-2028
6.5.3 Japan Tourette Syndrome Treatment Market Size, 2017-2028
6.5.4 South Korea Tourette Syndrome Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Tourette Syndrome Treatment Market Size, 2017-2028
6.5.6 India Tourette Syndrome Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Tourette Syndrome Treatment Revenue, 2017-2028
6.6.2 Brazil Tourette Syndrome Treatment Market Size, 2017-2028
6.6.3 Argentina Tourette Syndrome Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tourette Syndrome Treatment Revenue, 2017-2028
6.7.2 Turkey Tourette Syndrome Treatment Market Size, 2017-2028
6.7.3 Israel Tourette Syndrome Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Tourette Syndrome Treatment Market Size, 2017-2028
6.7.5 UAE Tourette Syndrome Treatment Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Tourette Syndrome Treatment Major Product Offerings
7.1.4 AstraZeneca Tourette Syndrome Treatment Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Boehringer Ingelheim International GmbH
7.2.1 Boehringer Ingelheim International GmbH Corporate Summary
7.2.2 Boehringer Ingelheim International GmbH Business Overview
7.2.3 Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Major Product Offerings
7.2.4 Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Revenue in Global Market (2017-2022)
7.2.5 Boehringer Ingelheim International GmbH Key News
7.3 Eli Lilly and Co.
7.3.1 Eli Lilly and Co. Corporate Summary
7.3.2 Eli Lilly and Co. Business Overview
7.3.3 Eli Lilly and Co. Tourette Syndrome Treatment Major Product Offerings
7.3.4 Eli Lilly and Co. Tourette Syndrome Treatment Revenue in Global Market (2017-2022)
7.3.5 Eli Lilly and Co. Key News
7.4 Mylan NV
7.4.1 Mylan NV Corporate Summary
7.4.2 Mylan NV Business Overview
7.4.3 Mylan NV Tourette Syndrome Treatment Major Product Offerings
7.4.4 Mylan NV Tourette Syndrome Treatment Revenue in Global Market (2017-2022)
7.4.5 Mylan NV Key News
7.5 Otsuka Holdings Co. Ltd.
7.5.1 Otsuka Holdings Co. Ltd. Corporate Summary
7.5.2 Otsuka Holdings Co. Ltd. Business Overview
7.5.3 Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Major Product Offerings
7.5.4 Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Revenue in Global Market (2017-2022)
7.5.5 Otsuka Holdings Co. Ltd. Key News
7.6 Sanofi S.A.
7.6.1 Sanofi S.A. Corporate Summary
7.6.2 Sanofi S.A. Business Overview
7.6.3 Sanofi S.A. Tourette Syndrome Treatment Major Product Offerings
7.6.4 Sanofi S.A. Tourette Syndrome Treatment Revenue in Global Market (2017-2022)
7.6.5 Sanofi S.A. Key News
7.7 Pfizer Inc.
7.7.1 Pfizer Inc. Corporate Summary
7.7.2 Pfizer Inc. Business Overview
7.7.3 Pfizer Inc. Tourette Syndrome Treatment Major Product Offerings
7.7.4 Pfizer Inc. Tourette Syndrome Treatment Revenue in Global Market (2017-2022)
7.7.5 Pfizer Inc. Key News
7.8 Sun Pharmaceutical Industries Ltd
7.8.1 Sun Pharmaceutical Industries Ltd Corporate Summary
7.8.2 Sun Pharmaceutical Industries Ltd Business Overview
7.8.3 Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Major Product Offerings
7.8.4 Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Revenue in Global Market (2017-2022)
7.8.5 Sun Pharmaceutical Industries Ltd Key News
7.9 Neurocrine Biosciences, Inc.
7.9.1 Neurocrine Biosciences, Inc. Corporate Summary
7.9.2 Neurocrine Biosciences, Inc. Business Overview
7.9.3 Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Major Product Offerings
7.9.4 Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Revenue in Global Market (2017-2022)
7.9.5 Neurocrine Biosciences, Inc. Key News
7.10 Novartis AG
7.10.1 Novartis AG Corporate Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Tourette Syndrome Treatment Major Product Offerings
7.10.4 Novartis AG Tourette Syndrome Treatment Revenue in Global Market (2017-2022)
7.10.5 Novartis AG Key News
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.11.3 Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Major Product Offerings
7.11.4 Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Revenue in Global Market (2017-2022)
7.11.5 Teva Pharmaceutical Industries Ltd. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Tourette Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Tourette Syndrome Treatment Market Drivers in Global Market
Table 3. Tourette Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Tourette Syndrome Treatment in Global Market
Table 5. Top Tourette Syndrome Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tourette Syndrome Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tourette Syndrome Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tourette Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Tourette Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tourette Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Tourette Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tourette Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tourette Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Tourette Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tourette Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tourette Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Tourette Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tourette Syndrome Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tourette Syndrome Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tourette Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tourette Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tourette Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tourette Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tourette Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Tourette Syndrome Treatment Product Offerings
Table 32. AstraZeneca Tourette Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Boehringer Ingelheim International GmbH Corporate Summary
Table 34. Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Product Offerings
Table 35. Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly and Co. Corporate Summary
Table 37. Eli Lilly and Co. Tourette Syndrome Treatment Product Offerings
Table 38. Eli Lilly and Co. Tourette Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Mylan NV Corporate Summary
Table 40. Mylan NV Tourette Syndrome Treatment Product Offerings
Table 41. Mylan NV Tourette Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Otsuka Holdings Co. Ltd. Corporate Summary
Table 43. Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Product Offerings
Table 44. Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi S.A. Corporate Summary
Table 46. Sanofi S.A. Tourette Syndrome Treatment Product Offerings
Table 47. Sanofi S.A. Tourette Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Inc. Corporate Summary
Table 49. Pfizer Inc. Tourette Syndrome Treatment Product Offerings
Table 50. Pfizer Inc. Tourette Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Sun Pharmaceutical Industries Ltd Corporate Summary
Table 52. Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Product Offerings
Table 53. Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Neurocrine Biosciences, Inc. Corporate Summary
Table 55. Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Product Offerings
Table 56. Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Novartis AG Corporate Summary
Table 58. Novartis AG Tourette Syndrome Treatment Product Offerings
Table 59. Novartis AG Tourette Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 61. Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Product Offerings
Table 62. Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Tourette Syndrome Treatment Segment by Type in 2021
Figure 2. Tourette Syndrome Treatment Segment by Application in 2021
Figure 3. Global Tourette Syndrome Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tourette Syndrome Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tourette Syndrome Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tourette Syndrome Treatment Revenue in 2021
Figure 8. By Type - Global Tourette Syndrome Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tourette Syndrome Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tourette Syndrome Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tourette Syndrome Treatment Revenue Market Share, 2017-2028
Figure 12. US Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tourette Syndrome Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tourette Syndrome Treatment Revenue Market Share, 2017-2028
Figure 24. China Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tourette Syndrome Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tourette Syndrome Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tourette Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Tourette Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly and Co. Tourette Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mylan NV Tourette Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi S.A. Tourette Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Inc. Tourette Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Novartis AG Tourette Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
